S100A16 is involved in various tumors, such as colorectal cancer, bladder cancer, pancreatic cancer, lung adenocarcinoma, cervical cancer, leukemia, and gastric cancer [37–43]. This evidence concerns the gene S100A16 and urinary bladder carcinoma.